Skip to main content

Table 1 Haemodynamic values for each group at baseline and after fluid resuscitation and norepinephrine infusion

From: Midazolam increases preload dependency during endotoxic shock in rabbits by affecting venous vascular tone

 

T0

T1

T2

T3

Control

MID1

MID2

Control

MID1

MID2

Control

MID1

MID2

Control

MID1

MID2

HR (/min)

220 [213–221]

221 [219–229]

222 [219–226]

192 [190–192]

201 [191–204]

191 [190–194]

188 [185–191]

219 [215–228]*&

218 [211–224]*&

193 [191–195]

202 [189–203]^

192 [191–194]^

SBP (mmHg)

131 [130–134]

130 [129–130]

130 [126–135]

142 [136–150]

148 [141–151]

146 [141–152]

143 [137–150]

129 [126–133]*&

108 [107–108]*#&

135 [131–141]

137 [135–138]&

142 [135–147]^

DBP (mmHg)

78 [76–80]

79 [75–80]

77 [75–80]

84 [81–85]

86 [82–88]

88 [82–89]

80 [79–84]

71 [70–77]&

57 [56–60]*#&

79 [78–82]

80 [76–80]^

77 [76–78]&^

MAP (mmHg)

96 [92–98]

94 [93–96]

96 [92–97]

105 [98–108]

104 [101–108]

106 [104–110]

103 [95–107]

90 [87–95]*&

74 [72–76]*#&

99 [96–103]

98 [97–99]&^

97 [96–99]&^

CVP (mmHg)

0 [0–1]

1 [0–1]

0 [0–0]

4 [3, 4]

4 [3–5]

2 [2–4]

4 [3–4]

3 [3–3]&

1 [1–2]*#&

4 [3–4]

5 [4–5]^

3 [2–4]^

CO (L/min)

0.70 [0.68–0.70]

0.71 [0.69–0.72]

0.79 [0.77–0.81]

0.97 [0.95–0.98]

0.90 [0.89–0.96]

0.96 [0.95–1.01]

0.97 [0.95–1.00]

0.83 [0.82–0.88]*&

0.74 [0.71–0.76]*&

0.97 [0.95–0.98]

0.90 [0.89–0.96]^

0.96 [0.95–1.01]^

SV (mL)

3.16 [2.97–3.42]

3.19 [3.13–3.40]

3.53 [3.46–3.64]

5.04 [4.97–5.09]

4.77 [4.48–4.84]

4.96 [4.82–5.28]

5.04 [4.91–5.13]

3.96 [3.76–4.07]*&

3.42 [3.18–3.67]*&

4.99 [4.93–5.06]

4.72 [4.46–4.94]^

4.96 [4.81–5.25]^

GEDV (mL)

51.73 [50.96,51.95]

52.61 [52.42,53.10]

52.29 [51.96,52.93]

85.10 [79.61,91.04]

83.68 [80.95,86.80]

84.04 [77.73,85.20]

85.60 [79.14,90.79]

79.88 [74.58,81.53]&

61.15 [58.22,63.21]*#&

85.15 [79.36,90.35]

87.28 [81.01,87.96]^

84.84 [77.70,87.06]^

PPV (%)

19 [17–21]

17 [16–21]

18 [17–19]

12 [9–14]

9 [7–10]

9 [8–10]

12 [10–14]

14 [12–14]&

18 [17–20]*#&

12 [10–14]

10 [10–11]

11 [9–12]^

SVV (%)

20 [18–22]

19 [17–21]

17 [16–21]

12 [11–13]

9 [7–10]

10 [8–10]

11 [10–12]

15 [14–16]*&

19 [18–20]*#&

11 [10–12]

10 [9–11]^

10 [8–10]^

Pmsf (mmHg)

11.38 [10.66–11.74]

11.25 [9.82–12.18]

10.21 [9.84–10.83]

15.10 [14.37–15.33]

15.25 [12.80–15.90]

13.66 [13.32–14.44]

13.96 [12.62–15.19]

11.99 [11.39–12.33]*&

7.47 [7.12–8.18]*#&

15.04 [14.43–15.21]

14.67 [13.05–16.48]^

13.84 [11.78–14.05]^

Rsys (mmHg min kg/L)

433.07 [407.43–467.57]

425.39 [415.13–447.27]

391.68 [385.29–396.17]

313.44 [285.22–349.96]

344.17 [335.74–378.40]

345.42 [329.23–359.34]

307.07 [275.76–354.48]

325.91 [319.91–364.31]

321.84 [315.46–330.69]

304.85 [277.58–330.59]

330.35 [329.47–345.24]

311.64 [295.34–331.80]

Ra (mmHg min kg/L)

381.99 [359.36–415.32]

376.87 [371.82–395.45]

351.96 [348.17–354.64]

281.67 [246.52–309.64]

309.23 [297.37–339.03]

315.84 [291.55–322.58]

277.14 [238.35–317.62]

294.21 [284.26–328.25]

295.30 [286.45–306.61]

268.01 [240.22–293.72]

294.57 [288.36–300.60]

279.84 [267.47–298.88]

Rvr (mmHg min kg/L)

50.00 [47.22–52.25]

47.09 [44.35–51.98]

42.41 [38.80–44.46]

37.02 [30.15–39.24]

39.42 [35.58–39.94]

37.12 [32.12–39.78]

36.71 [26.93–37.80]

36.04 [33.01–36.69]

28.05 [26.93–29.48]#&

36.80 [29.28–41.45]

36.90 [29.71–41.42]

32.08 [30.10–33.84]

CFI (/min)

13.41 [13.25–13.51]

13.52 [13.22–13.55]

14.89 [14.35–15.52]

11.82 [11.33–12.46]

10.97 [10.62–11.19]

12.23 [11.54–12.30]

11.86 [11.29–12.49]

10.81 [10.25–11.29]

12.26 [11.34–12.46]

11.86 [11.29–12.49]

10.81 [10.25–11.29]

12.26 [11.34–12.46]

  1. The table shows the recorded haemodynamic values expressed as medians (IQR) of animal preparation at baseline (T0), after fluid resuscitation and norepinephrine infusion (T1), after midazolam infusion (T2) and after the second round of fluid resuscitation (T3) in the Control, MID1 and MID2 groups
  2. HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, CVP central venous pressure, CO cardiac output, SV stroke volume, GEDV global end-diastolic volume, PPV pulse pressure variation, SVV stroke volume variation, Pmsf mean systemic filling pressure, Rsys systemic vascular resistance, Ra resistance for artery, Rvr resistance for venous return, CFI Cardiac Function Index
  3. *p < 0.05 versus Control, #p < 0.05 versus MID1, p < 0.05 versus T0, &p < 0.05 versus T1, ^p < 0.05 versus T2, n = 6